Top Markets
#1 Akedo Akedo +70.44%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.33%
#4 Cross Cross +45.97%
#5 Velvet Velvet +34.78%
#6 Black Phoenix Black Phoenix +34.22%
#7 OVERTAKE OVERTAKE +21.57%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.16%
#9 Movement Movement +13.74%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +13.14%
Coin of the day
Akedo Akedo
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Lifecare AS Lifecare AS

Lifecare AS

LIFE
Rangering i aksjer #39121
Based in Norway, Lifecare AS is dedicated to the research and advancement of... Based in Norway, Lifecare AS is dedicated to the research and advancement of medical sensor technology for health tracking. A key innovation is Sencell, a compact sensor designed specifically for continuously monitoring glucose levels in diabetic patients. The company, which has its corporate headquarters in Bergen, Norway, commenced operations in 2006.
Aksjekurs
$0.03333131
Markedsverdi
$636.22K
Endring (1 dag)
-0.63%
Endring (1 år)
-98.08%
Land
NO
Handel Lifecare AS (LIFE)

Kategori

Healthcare
Inntekter for Lifecare AS (LIFE)
Inntekter i 2026 TTM: 0
Ifølge Lifecare AS sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Lifecare AS fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -
US